Word: uh
(lookup in dictionary)
(lookup stats)
Dates: during 1990-1999
Sort By: most recent first
(reverse)
After all, you have to admit that we haven't exactly set the world on fire yet. Let's take a quick look at some of the features of our generation, what we've been able to offer to the world thus far. Contributions such as...uh...hmmm. There's so-called "alternative" rock, you know, music so edgy that you'll only find it on no fewer than four major radio stations at one time. Marcy Playground, please stand up and take a bow, then quickly return to your well-deserved obscurity...
...footer with deep-set eyes and a grin that creeps sideways across his face like a stock ticker, he has been labeled the world's brightest currency trader, an Einstein of the pits. Druckenmiller's paycheck is signed by George Soros, for whom he oversees $22 billion. Uh, make that a little less. Last week Druckenmiller watched helplessly as the Russian debt market vaporized into fiscal neutrinos, taking the last of $2 billion of Soros' Russia-invested money into hyperspace. Fessing up on CNBC, the crestfallen trader blinked at the camera and softly explained that the Moscow meltdown had turned...
...English," I volunteered, proud of my save. "Why?" he pursued. "Uh, because I like to read." Oh, I realized, that was not the right answer. What was anyway? Handy Man was becoming anxious, wondering where my mother was so he could finish and go home. I needed to keep the conversation going and distract him so he didn't just up and leave. It really was a challenge though because Sexy is as intelligent as the garage door he is waiting...
...gesticulating, for the light at 48th Street, and make a scathing, irrefutable point to, um, myself. It could be worse--Tourette's syndrome, for example. Tourette's sounds awful; this just looks crazy--or maybe a third of the way there. People in the street flick me a glance: "Uh...
...world of biotechnology, where each of some 300 public companies, including EntreMed, claims to have one or more wonder drugs in research. Those claims make terrific investment pitches, and on the heels of a successful new drug launch--Pfizer's impotence pill, Viagra, in this case--investors can get, uh, excited. The reality, though, is that maybe 10% of today's biotech companies will ever bring a blockbuster drug to the market. Those that do will enrich shareholders. But casual investors face long odds trying to be in the right stocks...